Abstract
Polyomavirus large T-antigen transgenic mice develop cardiac hypertrophy characterized by an increase in atrial natriuretic factor and β-myosin heavy chain isoform expression. The aim of this study was to examine changes in proto-oncogene expression in hypertrophied hearts from the transgenic mice. Expression of early growth response-1 (Egr-1) mRNA was detected in hearts from all 15 transgenic mice, but was not detectable in 13 control mice. Reverse transcriptase-polymerase chain reaction experiments usingEgr-1-specific primers confirmed the increase inEgr-1 mRNA in enlarged hearts from the transgenic mice. Expression of c-jun,junD and Ha-ras mRNAs was increased in the transgenic hearts 3, 17 and 2.8-fold, respectively. Western blots showed an increase in c-myc, c-jun and ras protein in hypertrophied transgenic hearts. Immunofluorescence analyses confirmed an increase in Egr-1 and c-jun protein in transgenic cardiomyocytes. Proliferating cell nuclear antigen, Ki-ras and HSP 90 mRNAs were decreased 22, 2.7 and 3-fold, respectively in the transgenic hearts. Not altered in most hypertrophied hearts was expression of c-fos, junB, p53, c-neu, c-myc, HSP70, HSP27, TGF-β or IGF-1 mRNAs. Proto-oncogene and growth factor gene expression in hypertrophy induced by PVLT expression is modulated, with some proto-oncogenes increased and others decreased in expression.
Similar content being viewed by others
References
Rakusan K: Cardiac growth, maturation and aging. In: Growth of the Heart in Health and Disease, edited by R. Zak. New York, Raven, 1984
Van Bilsen M, Chien KR: Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res 27: 1140–1149, 1993
Izumo S, Nadal-Ginard B, Mahdavi V: Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339–343, 1988
Komuro I, Kurobayashi M, Takaku M, Yazaki Y: Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy in the rat heart. Circ Res 62: 1075–1079, 1988
Schunkert H, Jahn L, Izumo S, Apstein CS, Lorell BH: Localization and regulation of c-fos and c-jun proto-oncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci USA 88: 11480–11484, 1991
Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross Jr J, Chien KR: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgenic in anin vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88:8277–8281, 1991
Green NK, Gammage MD, Frankly JA, Heagerty AM, Sheppard MC: Regulation of β-myosin heavy chain, c-myc and c-fos proto-oncogenes in thyroid hormone-induced hypertrophy of the rat myocardium. Clin Sci 84:61–67, 1993
Heagerty AM, Green NK, Maclver DH, Frankly JA, Gammage MD: Inositol phosphate production and proto-oncogene expression in the left ventricle after the induction of coarctation of the aorta in the rat. Br Heart J 61: 440–446, 1989
Komuro I, Kaoth Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y: Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem 266: 1265–1268, 1991
Mulvagh SL, Michael LH, Perryman MB, Roberts R, Schneider MD: A hemodynamic loadin vivo induces cardiac expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun 147: 627–636, 1987
Delcayre C, Samuel JL, Motte F, Best-Belpomme M, Mercadier JL, Rappaport L: Synthesis of stress protein in rat cardiac myocytes 2–4 days after the imposition of hemodynamic overload. J Clin Invest 82: 460–488, 1988
Sporn MB, Roberts AB: Transforming growth factor B: Recent progress and new challenges. J Cell Biol 119: 1017–1021, 1992
Thompson NL, Bazoberry F, Speir EG, Casscells W, Ferrans VJ, Flanders KC, Kondaiah P, Geiser AG, Sporn MB: Transforming growth factor B1 in acute myocardial infarction in rats. Growth Factors 1:91–99, 1988
Chalifour LE: Recent aspects of transgene technology. Current Opinion Therap Patents 1: 1821–1841, 1991
DePamphilis ML, Herman SA, Martinez-Salas E, Chalifour LE, Wirak DO, Cupo DY, Miranda M: Microinjecting DNA into mouse ova to study DNA replication and gene expression and to produce transgenic animals. BioTech 6: 662–680, 1988
Gruver CL, DeMayo F, Goldstein MA, Means AR: Targeted developmental overexpression of calmodulin induced proliferation and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrin 133: 376–388, 1994
Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RI: Myocardial expression of a constitutively active α1B-adrenergic receptor in transgenic mice induced cardiac hypertrophy. Proc Natl Acad Sci USA 91: 10109–10113, 1994
Chalifour LE, Gomes ML, Wang N-S, Mes-Masson A-M: Polyomavirus large T-antigen expression in heart of transgenic mice causes cardiomyopathy. Oncogene 5: 1719–1726, 1990
Chalifour LE, Mes-Masson A-M, Gomes ML, Wang N-S: Testicular adenoma and seminal vesicle engorgement in polyomavirus large T-antigen transgenic mice. Mol Carcino 5: 178–189, 1992
Al Moustafa A-E, Chalifour LE: Immortal cell lines isolated from heart differentiate to an endothelial lineage in the presence of retinoic acid. Cell Growth Differ 4: 851–847, 1994
Holder EL, Mitmaker B, Alpert L, Chalifour L: Morphometry and muscle gene expression in hypertrophied hearts from polyomavirus large T-antigen transgenic mice. Am I Physiol 269: H86-H95, 1995
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG7 Smith JA, Struhl K: Current Protocols in Molecular Biology. Greene Publishing Associated, Toronto, 1992
Chirgwin JM, Przybula AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochem 18: 5294–5299, 1979
Chalifour LE, Holder EL, Fahmy R, Hutchinson EW, Schipper HM, Wang E: A method for analysis of gene expression patterns. Anal Biochem 216: 299–304, 1994
McAllister HA Jr, Hall JR, Cooley DA: Surgical pathology of tumours and cysts of the heart and pericardium. In: Pathology of the Heart and Great Vessels, edited by BF Waller. Churchill Livingstone, New York, 1987
Kellerman S, Moore JA, Zierhut W, Zimmer H, Campbell J, Gerdes AM: Nuclear DNA content and nucleation pattern in rat cardiac myocytes from different models of cardiac hypertrophy. J Mol Cell Cardiol 24: 497–505, 1992
Soonpaa MH, Field LJ: Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol H1439–H1445, 1994
Jackson T, Allard MF, Sreenan CM, Doa LK, Bishop SP, Swain JL: The c-myc protooncogene regulated cardiac development in transgenic mice. Mol Cell Biol 10: 3709–3713, 1990
Tooze J: DNA Tumor Viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 1981
Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, vanDyke T, Harlow E: Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 64: 1353–1356, 1990
Field LF: Atrial natriuretic factor-SV40 T-antigen transgenes produce tumour and cardiac arrhythmias in mice. Science 239: 1029–1033, 1988
DeLeon JR, Federoff HJ, Dickson DW, Vikstrom KL, Fishman GI: Cardiac and skeletal myopathy in β myosin heavy-chain simian virus 40tsA58 transgenic mice. Proc Natl Acad Sci USA 91: 519–523, 1994
Pollack PS: Proto-oncogenes and the cardiovascular system Chest 107: 826–835, 1995
Sukhatme VP: The EGR transcription factor family: From signal transduction to kidney differentiation. Kidney Int 41: 550–553, 1992
Madden SL, Rauscher FJ: Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc-finger gene products. Ann N Y Acad Sci 684: 75–84, 1993
Gupta MP, Gupta M, Zak R, Sukhatme VP: Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac myosin heavy chain gene. J Biol Chem 266: 12813–12816, 1991
Sharma HS, Vanheugten HAA, Goedbloed MA, Verdouw PD, Lamers JMJ: Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Commun 205: 105–112, 1994
Neyes L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, Williams RS, Sukhatme VP, Vetter H: Induction of immediate early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hyperten 11: 927–934, 1993
Iwaki K, Sukhatme VP, Shubeita HE, Chien KR: α- and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem 265: 13809–13817, 1990
Lee SL, Tourtellotte L-AC, Wesselschmidt RL, Milbrandt J: Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J Biol Chem: 270: 9971–9977, 1995
Jackulski D, DeReil JK, Mercer WE, Calabretta B, Baserga R: Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 240: 1544–1546, 1988
Marino TA, Haldar S, Williamson EC, Beaverson K, Walter RA, Marino DR, Beatty C, Lipson KE: Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells. Circ Res 69: 1354–1360, 1991
Huang R-P, Darland T, Okamura D, Mercola D, Adamson ED: Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9: 1367–1377, 1994
Rappaport L, Contard F, Dubus 1, Swynghedauw B, Samuel JL: Stress-induced proto-oncogenes in the myocardium. Meth Ach Exp Pathol 15: 84–103, 1991
McMahon SB, Monroe JG: Activation of the p21 (ras) pathway couples antigen receptor stimulation to induction of the primary response gene egr-1 in B lymphocytes. J Exp Med 181: 417–422, 1995
Huang R-P, Adamson ED: A biological role for Egr-1 in cell survival following ultra-violet irradiation. Oncogene 10: 467–475, 1995
Sutherland JA, Cook A, Bannister AJ, Kouzarides T: Conserved motifs in fos and jun define a new class of activation domain. Genes & Devel 6: 1810–1819, 1992
Abate C, Curran T: Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol 1: 19–26, 1990
Thorburn A, Thorburn J, Chen S-Y, Powers S, Shubeita HE, Feramisco JR, Chien KR: HRas dependent pathways can activate morphological and genetic markers of cardiac cell hypertrophy. J Biol Chem 268: 2244–2249, 1993
Donahue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein IA, Slater WS, Catanese VW: Induction of myocardial insulin-like growth factor-1 gene expression in left ventricular hypertrophy. Circ 89: 799–809, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holder, E.L., Moustafa, AE.A. & Chalifour, L.E. Molecular remodelling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice. Mol Cell Biochem 152, 131–141 (1995). https://doi.org/10.1007/BF01076075
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01076075